Kaipharm ^Company

Kaipharm is an AI-driven drug discovery company that specializes in virtual drug screening and drug-induced transcriptome data. They have developed a unique drug virtual screening algorithm based on big data and artificial intelligence, which allows them to provide comprehensive drug discovery solutions. Their main project, KMAP, focuses on producing large drug-induced transcriptome data using next-generation sequencing and finding repositioning drugs. Additionally, Kaipharm offers drug virtual screening services using their patented algorithms, BEAR and BACoN, which analyze large-scale drug screening data to improve prediction accuracy. With their innovative technologies and extensive research experience, Kaipharm aims to revolutionize the field of drug discovery.